Ingrid Martinez
Family · South Miami, FLNPI 1740887629
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,056 of the $5,259 with a category attached, or 77.1%. 37 manufacturers reported payments, led by Merck at 25.9% of the total. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $32.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- Johnson & Johnson$384
- Daiichi Sankyo Inc.$354
- Pfizer$296
- Pharmaessentia USA Corporation$286
- AstraZeneca$282
- plus $2K from 31 others
What the payments were for
- Travel & lodging$87017%
- Food & beverage$4,05677%
- Education$3336%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $1,363 |
| Johnson & Johnson | 10 | $384 |
| Daiichi Sankyo Inc. | 12 | $354 |
| Pfizer | 13 | $296 |
| Pharmaessentia USA Corporation | 12 | $286 |
| AstraZeneca(2 entities) | 12 | $282 |
| AbbVie | 10 | $265 |
| Lilly USA, LLC | 6 | $203 |
| Sobi, Inc | 5 | $176 |
| Novartis | 6 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $135 |
| Incyte Corporation | 4 | $105 |
| Seagen Inc. | 1 | $99 |
| Bayer | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| Jazz Pharmaceuticals Inc. | 3 | $80 |
| Pharmacosmos Therapeutics Inc. | 4 | $77 |
| Array Biopharma Inc | 3 | $76 |
| Sanofi | 2 | $64 |
| Tempus AI, Inc | 3 | $62 |
| Gilead | 2 | $56 |
| ADC Therapeutics America, Inc. | 2 | $52 |
| Caris MPI, Inc. | 2 | $51 |
| Agios Pharmaceuticals, Inc. | 2 | $49 |
| Stemline Therapeutics Inc. | 2 | $49 |
| Novocure Inc. | 2 | $49 |
| Servier Pharmaceuticals LLC | 2 | $47 |
| GSK | 2 | $43 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Coherus Oncology, Inc. | 1 | $29 |
| Mirati Therapeutics, Inc. | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| EMD Serono, Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,259 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in South Miami
- Darlena BanasSouth Miami$64K
- Naime Reyno RamosSouth Miami$44K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.